The cognitive effects men with advanced prostate cancer experience during treatment may vary based on the therapy they ...

For the first time, therapeutically effective medications are now available for Alzheimer's disease. Effective symptomatic ...

Blood‑based biomarkers offer a real opportunity to improve dementia care – but only if we redesign our systems to use them ...

Background Hearing loss (HL) imposes a substantial burden on families and society and is the largest modifiable risk factor ...

The small pauses and “ums” in everyday conversations may reveal far more about your brain health than scientists once ...

Dementia is often misunderstood as a common, almost normal, part of ageing. But medical experts consider it a progressive ...

Keith Alan Pavlick says caring for his dad amid dementia and rising elder care costs has taken over his life and forced him ...

From the subtle differences between memory lapses and brain disease to the lifestyle changes that can lower your risk, Dr Tim Beanland at Alzheimer’s Society helps you navigate the facts about dementi ...

Elecsys pTau217 is the first blood test for Alzheimer's disease pathology with a single-assay design, intended to rule in and rule out amyloid pathology across primary and secondary care, offering fas ...

Elecsys® pTau217 is the first blood test for Alzheimer’s disease pathology with a single‑assay design, intended to rule in ...

Join Dementia Research has reached 100,000 volunteers, but more are needed to drive breakthroughs in dementia research.

In the final stages of his dementia, a long-lost memory from childhood returned, perfectly formed. What was going on in his brain? Images of the writer’s father in his childhood, from a family photo ...